Oxalic Acid

Oxalic Acid

SCHEMBL9404430

CN(C)Cc1cc(C2=C(Cl)CCNC2)no1.O=C(O)C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
POLB P06746 1/20 0.34
USP30 Q70CQ3 2/20 0.33
LMNA P02545 1/20 0.32
NOTUM Q6P988 1/20 0.32
JAK2 O60674 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9404480 0.85 NOTUM (0.43) CHRNB2CHRNA4POLBLMNANOTUM
Oxalic Acid SCHEMBL9404355 0.83 PPARA (0.41) CHRNB2CHRNA4POLBJAK2ALDH1A1
Oxalic Acid SCHEMBL9404484 0.80 POLB (0.36) CHRNA4POLBALDH1A1HTTSMN1; SMN2
SCHEMBL9404483 0.77 MAPT (0.34) CHRNB2CHRNA4POLBNOTUMJAK2
SCHEMBL9404435 0.72 USP30 (0.35) CHRNB2CHRNA4POLBUSP30LMNA
SCHEMBL9404357 0.71 USP30 (0.41) CHRNB2CHRNA4POLBUSP30LMNA
Oxalic Acid SCHEMBL9404318 0.70 CHRNA4 (0.31) CHRNA4
Oxalic Acid SCHEMBL9404275 0.64 CHRM2 (0.42) LMNAALDH1A1HTTL3MBTL1
SCHEMBL20031303 0.62 NOTUM (0.62) POLBLMNANOTUMSMN1; SMN2L3MBTL1
SCHEMBL9548297 0.62 PPARA (0.52) CHRNB2CHRNA4LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5356912-A 3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease NOVO NORDISK A/S (DK) 1994-10-18 US disclosed
US-5262427-A Cognition activators for Alzheimer*s disease NOVO NORDISK A/S (DK) 1993-11-16 US disclosed
EP-0316718-A2 Azacyclic compounds and their preparation and use NOVO NORDISK A/S (DK) 1989-05-24 EP disclosed